INO-4995

Star0

DB17834ExperimentalSmall molecule

INO-4995 is an inositol tetrakisphosphate analog being investigated for Cystic Fibrosis.

Mechanism: Pharmacologically active on Anoctamin-1
Curator reviewed
Formula / weight: C₅₀H₈₆O₃₅P₄ · 1371.098 g/mol (avg)
Also known as: 2-O-butyryl-1-O-octyl-myo-Inositol 3,4,5,6-tetrakisphosphate octakis(propionoxymethyl)ester
Code names: INO-4995

Resolves to

Compound

UNII3LM5SX2N4XCAS868171-91-9

Structure

InChIKeySVJGGWZOTSJMCQ-RMTIMQEASA-NSMILES

CCCCCCCCO[C@@H]1[C@H](OC(=O)CCC)[C@H](OP(=O)(OCOC(=O)CC)OCOC(=O)CC)[C@@H](OP(=O)(OCOC(=O)CC)OCOC(=O)CC)[C@H](OP(=O)(OCOC(=O)CC)OCOC(=O)CC)[C@H]1OP(=O)(OCOC(=O)CC)OCOC(=O)CC

Targets

Q5XXA6ANO1

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with INO-4995, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account